MNST
45
-21
ESS
62
-3
MCHP
34
-2
STT
64
2
ICE
59
-3
YUM
43
-6
LB
30
4
HRB
59
2
MMM
35
-5
JBHT
56
-3
KLAC
38
-6
ACN
47
-5
EOG
56
-2
JNPR
50
-6
HUM
41
-4
PVH
60
-4
ADBE
47
-9
LH
40
-5
CMS
60
2
TSN
50
-2
MNST
45
-21
ESS
62
-3
MCHP
34
-2
STT
64
2
ICE
59
-3
YUM
43
-6
LB
30
4
HRB
59
2
MMM
35
-5
JBHT
56
-3
KLAC
38
-6
ACN
47
-5
EOG
56
-2
JNPR
50
-6
HUM
41
-4
PVH
60
-4
ADBE
47
-9
LH
40
-5
CMS
60
2
TSN
50
-2
Financhill
Back

ParkVida Group Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
38

PRKV
ParkVida Group

Last Price:
0.0049
Seasonality Move:
-5.68%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
38
ParkVida Group (PRKV) is a Sell

Is ParkVida Group a Buy, Sell or Hold?

  • The current ParkVida Group [PRKV] share price is $0.0049. The Score for PRKV is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • PRKV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRKV Stock Price Chart

What is ParkVida Group's stock price today?

  • The ParkVida Group share price today is $0.0049
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRKV is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

PRKV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 0.03 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.0065 - 0.0065) Sell
Bollinger Bands (100): (0.0069 - 0.0069) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

PRKV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.01 Sell
20-day SMA: 0.01 Sell
50-day SMA: 0.01 Sell
200-day SMA: 0.01 Sell
8-day EMA: 0.01 Sell
20-day EMA: 0.01 Sell
50-day EMA: 0.01 Sell
200-day EMA: 0.01 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

ParkVida Group Earnings Growth & PRKV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

ParkVida Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):